The Trump administration has announced up to $4.9 million in federal funding for the first US studies examining ibogaine as a potential treatment for post-traumatic stress disorder in military veterans.
Health Secretary Robert F. Kennedy Jr. and Veterans Affairs Secretary Doug Collins announced the initiative on Thursday.
Ibogaine remains classified as an illegal substance in the United States and carries serious safety risks, including irregular heart rhythms.
Treatment courses at private clinics reportedly cost between $10,000 and $20,000 and require emergency medical monitoring. Officials said additional funding could support research into its potential use for addiction treatment.
Related Tweet:
Trump administration will fund new research on controversial psychedelic drug ibogaine https://t.co/b5NInzwPh4
— O.C. Register (@ocregister) November 12, 2026
Also Read:

